CURX - יחס חוב להיוון בספרים curanexpharma.com

The percentage of debt participation in the balance sheet capital of Curanex Pharmaceuticals Inc (CURX) demonstrates credit leverage dynamics, where the value 0.06 serves as a baseline reliability indicator. Curanex Pharmaceuticals Inc (CURX) relies on developing agents for long-term gastrointestinal therapy protected by patents. However, R&D activity is currently minimal and limited to licensing. Sales stability is maintained through specialized climate-controlled delivery via pharmacy chains.

This ratio determines the extent to which the capital structure depends on borrowed funds. By analyzing the trend of liabilities to book capitalization, an investor assesses the risk of excessive leverage. The metric is calculated as the ratio of total debt to total equity. For Curanex Pharmaceuticals Inc (CURX), a low level of borrowing is critically important, as it creates a financial buffer during raw material supply chain disruptions and challenges with foreign patent protection.